IGF-I in epithelial ovarian cancer and its role in disease progression

Growth Factors

Volumn 25, Issue 5, 2007, Pages 346-354

  Brokaw, Jane ^a   Katsaros, Dionyssios ^b   Wiley, Andrew ^a   Lu, Lingeng ^a   Su, Dan ^a   Sochirca, Olga ^b   de la Longrais, Irene A Rigault ^b   Mayne, Susan ^a   Risch, Harvey ^a   Yu, Herbert ^a  

^a YALE CANCER CENTER   (United States)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

IGF 1; IGF1A; IGF1B; Ovarian cancer

Indexed keywords

ADENINE; CELL PROTEIN; CYTOSINE; GENOMIC DNA; MESSENGER RNA; RNA; SOMATOMEDIN; SOMATOMEDIN C; SOMATOMEDIN CA; SOMATOMEDIN CB; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AUTOCRINE EFFECT; CANCER GROWTH; CLINICAL FEATURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CYTOSOL; DINUCLEOTIDE REPEAT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CANCER; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; ALTERNATIVE SPLICING; CELL COMMUNICATION; DISEASE PROGRESSION; FEMALE; GENOTYPE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MIDDLE AGED; OVARIAN NEOPLASMS; PHENOTYPE; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS);

EID: 38849133419     PISSN: 08977194     EISSN: 10292292     Source Type: Journal    
DOI: 10.1080/08977190701838402     Document Type: Article

References (34)

1. Cleveland, RJ, Gammon, MD, Edmiston, SN, Teitelbaum, SL, Britton, JA, Terry, MB, Eng, SM, Neugut, AI, Santella, RM and Conway, K. (2006) IGF1 CA repeat polymorphisms, lifestyle factors and breast cancer risk in the Long Island Breast Cancer Study Project. Carcinogenesis, 27, pp. 758-765.
2. DeLellis, K., Ingles, S., Kolonel, L., McKean-Cowdin, R., Henderson, B., Stanczyk, F. and Probst-Hensch, NM (2003) IGF1 genotype, mean plasma level and breast cancer risk in the Hawaii/Los Angeles multiethnic cohort. Br J Cancer, 88, pp. 277-282.
3. Friedrichsen, DM, Hawley, S., Shu, J., Humphrey, M., Sabacan, L., Iwasaki, L., Etzioni, R., Ostrander, EA and Stanford, JL (2005) IGF-I and IGFBP-3 polymorphisms and risk of prostate cancer. Prostate, 65, pp. 44-51.
4. Gebhardt, F., Zanker, KS and Brandt, B. (1999) Modulation of epidermal growth factor receptor gene transcription by a polymorphic dinucleotide repeat in intron 1. J Biol Chem, 274, pp. 13176-13180.
5. Gotlieb, WH, Bruchim, I., Gu, J., Shi, Y., Camirand, A., Blouin, MJ, Zhao, Y. and Pollak, MN (2006) Insulin-like growth factor receptor I targeting in epithelial ovarian cancer. Gynecol Oncol, 100, pp. 389-396.
6. Haluska, P., Carboni, JM, Loegering, DA, Lee, FY, Wittman, M., Saulnier, MG, Frennesson, DB, Kalli, KR, Conover, CA, Attar, RM, Kaufmann, SH, Gottardis, M. and Erlichman, C. (2006) In vitro and in vivo antitumor effects of the dual insulin-like growth factor-I/insulin receptor inhibitor, BMS-554417. Cancer Res 66, pp. 362-371.
7. Heintz, AP, Odicino, F., Maisonneuve, P., Beller, U., Benedet, JL, Creasman, WT, Ngan, HY and Pecorelli, S. (2003) Carcinoma of the ovary. Int J Gynaecol Obstet, 83, pp. 135-166.
8. Jernstrom, H., Chu, W., Vesprini, D., Tao, Y., Majeed, N., Deal, C., Pollak, M. and Narod, SA (2001) Genetic factors related to racial variation in plasma levels of insulin-like growth factor-1: Implications for premenopausal breast cancer risk. Mol Genet Metab, 72, pp. 144-154.
9. Jernstrom, H., Deal, C., Wilkin, F., Chu, W., Tao, Y., Majeed, N., Hudson, T., Narod, SA and Pollak, M. (2001) Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in healthy premenopausal women. Cancer Epidemiol Biomarkers Prev, 10, pp. 377-384.
10. Jernstrom, H., Sandberg, T., Bageman, E., Borg, A. and Olsson, H. (2005) Insulin-like growth factor-1 (IGF1) genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating IGF-1 levels: Implications for risk of early-onset breast cancer in young women from hereditary breast cancer families. Br J Cancer, 92, pp. 857-866.
11. Jones, JI and Clemmons, DR (1995) Insulin-like growth factors and their binding proteins: Biological actions. Endocr Rev 16, pp. 3-34.
12. Karasik, A., Menczer, J., Pariente, C. and Kanety, H. (1994) Insulin-like growth factor-I (IGF-I) and IGF-binding protein-2 are increased in cyst fluids of epithelial ovarian cancer. J Clin Endocrinol Metab, 78, pp. 271-276.
13. Li, L., Cicek, MS, Casey, G. and Witte, JS (2004) No association between genetic polymorphisms in IGF-I and IGFBP-3 and prostate cancer. Cancer Epidemiol Biomarkers Prev, 13, pp. 497-498.
14. Lukanova, A., Lundin, E., Toniolo, P., Micheli, A., Akhmedkhanov, A., Rinaldi, S., Muti, P., Lenner, P., Biessy, C., Krogh, V., Zeleniuch-Jacquotte, A., Berrino, F., Hallmans, G., Riboli, E. and Kaaks, R. (2002) Circulating levels of insulin-like growth factor-I and risk of ovarian cancer. Int J Cancer, 101, pp. 549-554.
15. Missmer, SA, Haiman, CA, Hunter, DJ, Willett, WC, Colditz, GA, Speizer, FE, Pollak, MN and Hankinson, SE (2002) A sequence repeat in the insulin-like growth factor-1 gene and risk of breast cancer. Int J Cancer, 100, pp. 332-336.
16. Morimoto, LM, Newcomb, PA, White, E., Bigler, J. and Potter, JD (2005) Insulin-like growth factor polymorphisms and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev, 14, pp. 1204-1211.
17. Neuhausen, SL, Slattery, ML, Garner, CP, Ding, YC, Hoffman, M. and Brothman, AR (2005) Prostate cancer risk and IRS1 IRS2, IGF1, and INS polymorphisms: Strong association of IRS1 G972R variant and cancer risk. Prostate, 64, pp. 168-174.
18. Pollak, MN, Schernhammer, ES and Hankinson, SE (2004) Insulin-like growth factors and neoplasia. Nat Rev Cancer, 4, pp. 505-518.
19. Resnicoff, M., Ambrose, D., Coppola, D. and Rubin, R. (1993) Insulin-like growth factor-1 and its receptor mediate the autocrine proliferation of human ovarian carcinoma cell lines. Lab Invest, 69, pp. 756-760.
20. Rietveld, I., Janssen, JA, van Rossum, EF, Houwing-Duistermaat, JJ, Rivadeneira, F., Hofman, A., Pols, HA, van Duijn, CM and Lamberts, SW (2004) A polymorphic CA repeat in the IGF-I gene is associated with gender-specific differences in body height, but has no effect on the secular trend in body height. Clin Endocrinol (Oxf), 61, pp. 195-203.
21. Schildkraut, JM, Demark-Wahnefried, W., Wenham, RM, Grubber, J., Jeffreys, AS, Grambow, SC, Marks, JR, Moorman, PG, Hoyo, C., Ali, S. and Walther, PJ (2005) IGF1 (CA)19 repeat and IGFBP3 -202 A/C genotypes and the risk of prostate cancer in Black and White men. Cancer Epidemiol Biomarkers Prev, 14, pp. 403-408.
22. Serov, S., Soully, RF and Sobin, LH (1973) Histological typing of ovarian tumors, World Health Organization, Geneva
23. Shen, MR, Lin, AC, Hsu, YM, Chang, TJ, Tang, MJ, Alper, SL, Ellory, JC and Chou, CY (2004) Insulin-like growth factor 1 stimulates KCl cotransport, which is necessary for invasion and proliferation of cervical cancer and ovarian cancer cells. J Biol Chem, 279, pp. 40017-40025.
24. Sjogren, K., Jansson, JO, Isaksson, OG and Ohlsson, C. (2002) A model for tissue-specific inducible insulin-like growth factor-I (IGF-I) inactivation to determine the physiological role of liver-derived IGF-I. Endocrine, 19, pp. 249-256.
25. Slattery, ML, Murtaugh, M., Caan, B., Ma, KN, Neuhausen, S. and Samowitz, W. (2005) Energy balance, insulin-related genes and risk of colon and rectal cancer. Int J Cancer, 115, pp. 148-154.
26. Tran, N., Bharaj, BS, Diamandis, EP, Smith, M., Li, BD and Yu, H. (2004) Short tandem repeat polymorphism and cancer risk: Influence of laboratory analysis on epidemiologic findings. Cancer Epidemiol Biomarkers Prev, 13, pp. 2133-2140.
27. Tsuchiya, N., Wang, L., Horikawa, Y., Inoue, T., Kakinuma, H., Matsuura, S., Sato, K., Ogawa, O., Kato, T. and Habuchi, T. (2005) CA repeat polymorphism in the insulin-like growth factor-I gene is associated with increased risk of prostate cancer and benign prostatic hyperplasia. Int J Oncol, 26, pp. 225-231.
28. Wagner, K., Hemminki, K., Israelsson, E., Grzybowska, E., Soderberg, M., Pamula, J., Pekala, W., Zientek, H., Mielzynska, D., Siwinska, E. and Forsti, A. (2005) Polymorphisms in the IGF-1 and IGFBP 3 promoter and the risk of breast cancer. Breast Cancer Res Treat, 92, pp. 133-140.
29. Welniak, LA, Karas, M., Yakar, S., Anver, MR, Murphy, WJ and LeRoith, D. (2004) Effects of organ-specific loss of insulin-like growth factor-I production on murine hematopoiesis. Biol Blood Marrow Transplant, 10, pp. 32-39.
30. Wen, W., Gao, YT, Shu, XO, Yu, H., Cai, Q., Smith, JR and Zheng, W. (2005) Insulin-like growth factor-I gene polymorphism and breast cancer risk in Chinese women. Int J Cancer, 113, pp. 307-311.
31. Wong, HL, Delellis, K., Probst-Hensch, N., Koh, WP, Berg, D Van Den, Lee, HP, Yu, MC and Ingles, SA (2005) A new single nucleotide polymorphism in the insulin-like growth factor I regulatory region associates with colorectal cancer risk in singapore chinese. Cancer Epidemiol Biomarkers Prev, 14, pp. 144-151.
32. Yee, D., Morales, FR, Hamilton, TC and Von Hoff, DD (1991) Expression of insulin-like growth factor I, its binding proteins, and its receptor in ovarian cancer. Cancer Res, 51, pp. 5107-5112.
33. Yu, H., Li, BD, Smith, M., Shi, R., Berkel, HJ and Kato, I. (2001) Polymorphic CA repeats in the IGF-I gene and breast cancer. Breast Cancer Res Treat, 70, pp. 117-122.
34. Zecevic, M., Amos, CI, Gu, X., Campos, IM, Jones, JS, Lynch, PM, Rodriguez-Bigas, MA and Frazier, ML (2006) IGF1 gene polymorphism and risk for hereditary nonpolyposis colorectal cancer. J Natl Cancer Inst, 98, pp. 139-143.